Sagimet Biosciences (SGMT) Liabilities and Shareholders Equity (2022 - 2026)
Sagimet Biosciences' Liabilities and Shareholders Equity came in at $263.43 million for Q2 2026, up 91.7% from $137.41 million a year earlier and up 144.5% from the prior quarter.
Powered by 
Analysis
Sagimet Biosciences (SGMT) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends
At the end of FY2025, Sagimet Biosciences' Liabilities and Shareholders Equity was $116.48 million, down 27.3% from FY2024.
- Liabilities and Shareholders Equity carries a three-year compound annual growth rate of 52.2% (FY2022 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $160.26 million in FY2024 (+65.7%), $96.72 million in FY2023 (+192.8%) and $33.03 million in FY2022.
- The Q2 2026 figure represents the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2022.
- Year-over-year, Liabilities and Shareholders Equity increased in three of the last eight quarters, with growth averaging 11.9%.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q2 2024 (growth of 779.2%), and the weakest in Q4 2025 (a decline of 27.3%).
- Business Quant data shows SGMT's Liabilities and Shareholders Equity at $107.76 million (Q1 2026), $116.48 million (Q4 2025) and $128.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Sagimet Biosciences | 524.77 Mn | 524.77 Mn | - | 263.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 263.43 Mn |
| Mar 31, 2026 | 107.76 Mn |
| Dec 31, 2025 | 116.48 Mn |
| Sep 30, 2025 | 128.40 Mn |
| Jun 30, 2025 | 137.41 Mn |
| Mar 31, 2025 | 146.17 Mn |
| Dec 31, 2024 | 160.26 Mn |
| Sep 30, 2024 | 174.78 Mn |
| Jun 30, 2024 | 189.02 Mn |
| Mar 31, 2024 | 194.53 Mn |
| Dec 31, 2023 | 96.72 Mn |
| Sep 30, 2023 | 102.93 Mn |
| Jun 30, 2023 | 21.50 Mn |
| Dec 31, 2022 | 33.03 Mn |
API Access
Sagimet Biosciences Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SGMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "SGMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SGMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();